CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2012-11-14

Name: CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2012-11-14
Creator: CHINA PHARMA HOLDINGS, INC.

What CHINA PHARMA HOLDINGS, INC. reported in its quarterly report filed 2012-11-14 (fiscal Q3 2012): 40 published measures, 112 facts as tagged in accession 0001010549-12-001213.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-11-14
Fiscal period: fiscal Q3 2012
Accession: 0001010549-12-001213 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PHARMA HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-09-30	166,046,823	USD
At 2011-12-31	156,390,991	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-09-30	16,711,986	USD
At 2011-12-31	13,907,894	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-09-30	149,334,837	USD
At 2011-12-31	142,483,097	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-09-30	5,061,766	USD
At 2011-12-31	4,050,854	USD
At 2011-09-30	4,852,740	USD
At 2010-12-31	3,692,086	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	2,969,934	USD	274
2011-01-01 to 2011-09-30	5,410,267	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-81,352	USD	274
2011-01-01 to 2011-09-30	-280,645	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	12,176,344	USD	92
2012-01-01 to 2012-09-30	42,861,478	USD	274
2011-07-01 to 2011-09-30	20,987,725	USD	92
2011-01-01 to 2011-09-30	58,708,134	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	393,004	USD	274
2011-01-01 to 2011-09-30	347,919	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-2,375,039	USD	274
2011-01-01 to 2011-09-30	-4,745,270	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-09-30	110,148,426	USD
At 2011-12-31	104,286,666	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	43,560,305	shares	92
2012-01-01 to 2012-09-30	43,560,305	shares	274
2011-07-01 to 2011-09-30	43,529,557	shares	92
2011-01-01 to 2011-09-30	43,463,165	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	0.03	USD/shares	92
2012-01-01 to 2012-09-30	0.13	USD/shares	274
2011-07-01 to 2011-09-30	0.11	USD/shares	92
2011-01-01 to 2011-09-30	0.35	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	0.03	USD/shares	92
2012-01-01 to 2012-09-30	0.13	USD/shares	274
2011-07-01 to 2011-09-30	0.11	USD/shares	92
2011-01-01 to 2011-09-30	0.35	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-244,452	USD	92
2012-01-01 to 2012-09-30	-1,147,965	USD	274
2011-07-01 to 2011-09-30	-927,845	USD	92
2011-01-01 to 2011-09-30	-2,670,115	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-09-30	5,818,475	USD
At 2011-12-31	6,334,817	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	141,721	USD	274
2011-01-01 to 2011-09-30	139,074	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,617,854	USD	92
2012-01-01 to 2012-09-30	7,242,172	USD	274
2011-07-01 to 2011-09-30	5,963,925	USD	92
2011-01-01 to 2011-09-30	17,062,648	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-09-30	118,702,058	USD
At 2011-12-31	110,608,686	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-79,507	USD	92
2012-01-01 to 2012-09-30	-235,516	USD	274
2011-07-01 to 2011-09-30	-62,438	USD	92
2011-01-01 to 2011-09-30	-184,874	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-09-30	16,541,230	USD
At 2011-12-31	13,778,985	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-09-30	69,819,575	USD
At 2011-12-31	69,695,556	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,625,938	USD	92
2012-01-01 to 2012-09-30	5,444,323	USD	274
2011-07-01 to 2011-09-30	1,551,964	USD	92
2011-01-01 to 2011-09-30	4,750,283	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-09-30	37,814,472	USD
At 2011-12-31	30,378,658	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	3,243,792	USD	92
2012-01-01 to 2012-09-30	12,686,495	USD	274
2011-07-01 to 2011-09-30	7,514,921	USD	92
2011-01-01 to 2011-09-30	21,666,516	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	8,932,552	USD	92
2012-01-01 to 2012-09-30	30,174,983	USD	274
2011-07-01 to 2011-09-30	13,472,804	USD	92
2011-01-01 to 2011-09-30	37,041,618	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-09-30	43,579,557	shares
At 2011-12-31	43,529,557	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-09-30	23,590,204	USD
At 2011-12-31	23,448,534	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-09-30	15,552,627	USD
At 2011-12-31	14,704,367	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-09-30	4,049,480	USD
At 2011-12-31	3,391,124	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2012-09-30	2,644,281	USD
At 2011-12-31	3,082,671	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-09-30	193,088	USD
At 2011-12-31	184,017	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,539,935	USD	92
2012-01-01 to 2012-09-30	7,009,725	USD	274
2011-07-01 to 2011-09-30	5,902,728	USD	92
2011-01-01 to 2011-09-30	17,817,690	USD	273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,295,483	USD	92
2012-01-01 to 2012-09-30	5,861,760	USD	274
2011-07-01 to 2011-09-30	4,974,883	USD	92
2011-01-01 to 2011-09-30	15,147,575	USD	273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,170,858	USD	92
2012-01-01 to 2012-09-30	6,710,020	USD	274
2011-07-01 to 2011-09-30	6,531,862	USD	92
2011-01-01 to 2011-09-30	19,552,543	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	598,258	USD	92
2012-01-01 to 2012-09-30	2,087,401	USD	274
2011-07-01 to 2011-09-30	621,336	USD	92
2011-01-01 to 2011-09-30	2,525,230	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2010-07-01 to 2012-09-30	638,219	USD	823
2009-07-01 to 2011-09-30	636,179	USD	822

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-77,919	USD	92
2012-01-01 to 2012-09-30	-232,447	USD	274
2011-07-01 to 2011-09-30	-61,197	USD	92
2011-01-01 to 2011-09-30	755,042	USD	273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-67,603	USD	274
2011-01-01 to 2011-09-30	67,789	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	1,343,957	USD	274
2011-01-01 to 2011-09-30	1,554,339	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-5,911,799	USD	274
2011-01-01 to 2011-09-30	-274,331	USD	273

Inspect the source

Entity: CHINA PHARMA HOLDINGS, INC. / CIK 0001106644
Captured: 2026-09-20T05:23:28.377Z
SEC response SHA-256: ad45dffd15d0f5a098ab8b6912816a8b1b845b1d791781ea412833d3178873c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001106644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))